Filter
1

Postoperative Analgesia Intervention With Non-opioid Alternatives (PAIN-Alt) Trial - Breast Surgery

for
Post Operative Pain, Opioid Analgesic Adverse Reaction, Surgery,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT06507345

Recruiting

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05800405

Early_phase1, Recruiting

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

for
Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT04741997

Early_phase1, Recruiting

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Saint Johnsbury VT, Lebanon NH, Lake Success NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04510597

Phase3, Recruiting

Hyperfractionated Dual Equivalent Fractionated Radiation Therapy

for
Diffuse Large B-Cell Lymphoma
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06898905

Recruiting

Interested in new gene therapy trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer

for
Metastatic Skin Squamous Cell Carcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04428671

Phase1, Recruiting

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

for
AML/MDS, B-ALL, T-ALL, BPDCN
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 21

Code: NCT04318678

Phase1, Recruiting

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

for
Severe Hemophilia A
Location: Greenville NC, Los Angeles CA
Sponsor: Pfizer

Sex: Male

Age: 12 - 70+

Code: NCT06703606

Phase1, Recruiting

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

for
Multiple Myeloma, Plasma Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05336383

Phase2, Recruiting

A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma

for
B Cell Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06213311

Phase2, Recruiting

Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease

for
Post-Treatment Lyme Disease
Location: East Syracuse NY
Sponsor: State University of New York - Upstate Medical University

Sex: All

Age: 18 - 70+

Code: NCT06611111

Early_phase1, Recruiting

Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered

for
Type 1 Diabetes Mellitus
Location: Toronto
Sponsor: LMC Diabetes & Endocrinology Ltd.

Sex: All

Age: 18 - 55

Code: NCT03838783

Recruiting

Mitigating the Pro-inflammatory Phenotype of Obesity

for
Blood Pressure, Diabetes, Obesity, Insulin Resistance,
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18 - 70+

Code: NCT04934228

Phase1, Recruiting

OurSleepKit To Support CPAP Adherence

for
Obstructive Sleep Apnea, CPAP Treatment, Treatment Adherence
Location: Pittsburgh PA
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18+

Code: NCT06621511

Recruiting

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma

for
Oropharyngeal Squamous Cell Carcinoma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT04852328

Phase2, Recruiting

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

for
B-Cell Non-Hodgkin's Lymphoma (NHL), Lymphoma, Non-Hodgkins,
Location: Dallas TX, Sacramento CA
Sponsor: Estrella Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT06343311

Phase1, Phase2, Recruiting

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT05052528

Phase1, Recruiting

Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma

for
Advanced Basal Cell Carcinoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT05651828

Early_phase1, Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Boston MA, Stoneham MA, Westerly RI, Waterford CT,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT04566328

Phase3, Recruiting

Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for Prevention

for
COPD Exacerbation Acute
Location: Rochester NY
Sponsor: Rochester General Hospital

Sex: All

Age: 18 - 70+

Code: NCT05764993

Phase2, Recruiting